Summary by Moomoo AI
ADIMAB, LLC, a 10% stockholder in Invivyd, Inc., is set to sell 5,000,000 shares of common stock on January 19, 2024. The shares, with an aggregate market value of $19,750,000, were originally acquired on August 6, 2021, through a private acquisition from the issuer. The acquisition was made in cash for a total of 26,687,906 shares. There have been no reported sales of securities by ADIMAB, LLC in the past three months.